Julia Żerdka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julia Żerdka has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Patryk Brasse
Student Scientific Club, Department of Cardiology, Faculty of Health Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland
5 shared publications - Eliza Kwapień
Medicine, Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary, Sosnowiec, POL
4 shared publications - Jakub Bartkowski
Medicine, Miejskie Zakłady Opieki Zdrowotnej w Żorach, Żory, POL
4 shared publications - Mateusz Piszka
General Practice, Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary w Sosnowcu, Sosnowiec, POL
4 shared publications - Aleksandra Owczarska
Provincial Specialist Hospital No. 5 named after St. Barbara in Sosnowiec
3 shared publications - Hubert Dacyl
Medical University of Silesia in Katowice, Poland
3 shared publications
Latest Publications
- Open Access
- 7 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5318
Prevalence and Correlates of Disposable E-Cigarette Use Among Adolescents and Young Adults in Southern Poland
Introduction: In recent years, electronic cigarettes, including disposable e-cigarettes and tobacco heating devices, have grown in popularity, especially among young people and young adults. Although e-cigarettes are touted as a “safer” alternative to traditional cigarettes, a growing body of evidence indicates that vaping can cause serious health problems, especially in the respiratory and cardiovascular systems. Aim of the Study: The aim of the study was to assess the prevalence of disposable e-cigarettes and other nicotine products among adolescents and young adults, as well as to examine the factors associated with regular smoking and nicotine dependence across individual nicotine-containing products. Material and Methods: The survey was conducted among residents of southern Poland. A total of 625 (100%) people were examined. Among them were: 350 women and 275 men. The subjects were aged between 14 and 29 years (Median and 25th–75th percentile: 19; 16–23). The study used an original questionnaire, the completion of which was anonymous and voluntary. The questions included in the survey concerned the smoking status of the respondents, the main sources of nicotine intake and general information such as age, gender, place of residence, employment or education, and financial stability of the family. The survey used the Fagerström test to examine the degree of nicotine dependence among the subjects. Results: A total of 34% (212; 33.92%) of the surveyed group of adolescents and young adults were smokers, most of whom used disposable e-cigarettes (69; 32.55%). In addition, 60% (368; 58.88%) of respondents reported having tried disposable e-cigarettes. Smokers, of both traditional cigarettes and e-cigarettes, accounted for 14% (88; 14.08%) of the study group. The results of the study showed a statistically significant effect of the age of the participants on the method of nicotine intake (p = 0.013). In the younger group, e-cigarettes were more often used, while in the older group, the use of heated tobacco products and traditional cigarettes dominated. Respondents’ median age at the first use of nicotine products was 16 years. Factors such as living in the city, lower financial stability, and having a parent who smoked during childhood were significantly associated with a higher likelihood of regular nicotine product use. Among the regular users, a high level of nicotine dependence was observed in 28.64% (n = 61) of individuals, with the largest proportion occurring among those using electronic cigarettes (39.37%; n = 50). Conclusions: 1. In the study group of adolescents and young adults, disposable e-cigarettes were the most used nicotine-containing product. 2. Parental smoking and male gender were positively associated with the likelihood of smoking, whereas primary education and financial stability were inversely associated with tobacco use. 3. Electronic cigarette users exhibited the highest average nicotine dependence scores. Multivariate analysis confirmed that male gender, the type of nicotine product used, and place of residence were independently associated with higher Fagerström test scores.
- 7 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5318
Open AccessPrevalence and Correlates of Disposable E-Cigarette Use Among Adolescents and Young Adults in Southern Poland
Introduction: In recent years, electronic cigarettes, including disposable e-cigarettes and tobacco heating devices, have grown in popularity, especially among young people and young adults. Although e-cigarettes are touted as a “safer” alternative to traditional cigarettes, a growing body of evidence indicates that vaping can cause serious health problems, especially in the respiratory and cardiovascular systems. Aim of the Study: The aim of the study was to assess the prevalence of disposable e-cigarettes and other nicotine products among adolescents and young adults, as well as to examine the factors associated with regular smoking and nicotine dependence across individual nicotine-containing products. Material and Methods: The survey was conducted among residents of southern Poland. A total of 625 (100%) people were examined. Among them were: 350 women and 275 men. The subjects were aged between 14 and 29 years (Median and 25th–75th percentile: 19; 16–23). The study used an original questionnaire, the completion of which was anonymous and voluntary. The questions included in the survey concerned the smoking status of the respondents, the main sources of nicotine intake and general information such as age, gender, place of residence, employment or education, and financial stability of the family. The survey used the Fagerström test to examine the degree of nicotine dependence among the subjects. Results: A total of 34% (212; 33.92%) of the surveyed group of adolescents and young adults were smokers, most of whom used disposable e-cigarettes (69; 32.55%). In addition, 60% (368; 58.88%) of respondents reported having tried disposable e-cigarettes. Smokers, of both traditional cigarettes and e-cigarettes, accounted for 14% (88; 14.08%) of the study group. The results of the study showed a statistically significant effect of the age of the participants on the method of nicotine intake (p = 0.013). In the younger group, e-cigarettes were more often used, while in the older group, the use of heated tobacco products and traditional cigarettes dominated. Respondents’ median age at the first use of nicotine products was 16 years. Factors such as living in the city, lower financial stability, and having a parent who smoked during childhood were significantly associated with a higher likelihood of regular nicotine product use. Among the regular users, a high level of nicotine dependence was observed in 28.64% (n = 61) of individuals, with the largest proportion occurring among those using electronic cigarettes (39.37%; n = 50). Conclusions: 1. In the study group of adolescents and young adults, disposable e-cigarettes were the most used nicotine-containing product. 2. Parental smoking and male gender were positively associated with the likelihood of smoking, whereas primary education and financial stability were inversely associated with tobacco use. 3. Electronic cigarette users exhibited the highest average nicotine dependence scores. Multivariate analysis confirmed that male gender, the type of nicotine product used, and place of residence were independently associated with higher Fagerström test scores.
- Open Access
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Teprotumumab as a Breakthrough in Thyroid Eye Disease Therapy: A Comprehensive Review
Background. Thyroid Eye Disease (TED) is a complex autoimmune condition associated with Graves' disease, causing disfigurement, visual impairment, and reduced quality of life. For decades, options were limited to non-specific anti-inflammatory treatments like glucocorticosteroids and radiotherapy, often failing to address symptoms like proptosis and diplopia. Identifying the insulin-like growth factor-1 receptor (IGF-1R) as a driver of TED pathophysiology led to targeted therapies.Aim. This study reviews teprotumumab as a breakthrough TED therapy, analyzing its mechanism, efficacy, and place in treatment algorithms relative to traditional methods.Material and methodsA literature review was conducted using databases (PubMed, Embase, ClinicalTrials.gov) for articles up to November 2025. Analysis prioritized pivotal trials (OPTIC, OPTIC-X), meta-analyses, and reviews focusing on TED pathophysiology and IGF-1R inhibition.Results. TED pathogenesis involves crosstalk between TSHR and IGF-1R on orbital fibroblasts, triggering inflammation and adipogenesis. While traditional treatments offer limited relief with side effects, teprotumumab, the first FDA-approved IGF-1R inhibitor, targets these mechanisms. Clinical data shows superior efficacy in reducing proptosis and improving diplopia compared to palliative care.Conclusions. Teprotumumab is a breakthrough in TED management, shifting from symptomatic to targeted disease modification. By addressing orbital remodeling causes, it offers distinct advantages over traditional therapies, fulfilling a major unmet need.
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Open AccessTeprotumumab as a Breakthrough in Thyroid Eye Disease Therapy: A Comprehensive Review
Background. Thyroid Eye Disease (TED) is a complex autoimmune condition associated with Graves' disease, causing disfigurement, visual impairment, and reduced quality of life. For decades, options were limited to non-specific anti-inflammatory treatments like glucocorticosteroids and radiotherapy, often failing to address symptoms like proptosis and diplopia. Identifying the insulin-like growth factor-1 receptor (IGF-1R) as a driver of TED pathophysiology led to targeted therapies.Aim. This study reviews teprotumumab as a breakthrough TED therapy, analyzing its mechanism, efficacy, and place in treatment algorithms relative to traditional methods.Material and methodsA literature review was conducted using databases (PubMed, Embase, ClinicalTrials.gov) for articles up to November 2025. Analysis prioritized pivotal trials (OPTIC, OPTIC-X), meta-analyses, and reviews focusing on TED pathophysiology and IGF-1R inhibition.Results. TED pathogenesis involves crosstalk between TSHR and IGF-1R on orbital fibroblasts, triggering inflammation and adipogenesis. While traditional treatments offer limited relief with side effects, teprotumumab, the first FDA-approved IGF-1R inhibitor, targets these mechanisms. Clinical data shows superior efficacy in reducing proptosis and improving diplopia compared to palliative care.Conclusions. Teprotumumab is a breakthrough in TED management, shifting from symptomatic to targeted disease modification. By addressing orbital remodeling causes, it offers distinct advantages over traditional therapies, fulfilling a major unmet need.
- Open Access
- 7 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
The impact of sleep duration and quality on the health of the pediatric population: consequences for mental health, eating disorders, and other diseases
Background Sleep is a fundamental biological process, the duration and quality of which are of key importance for the proper development and health of the pediatric population. Understanding the complex relationship between sleep and the pathogenesis of diseases during childhood is essential for developing effective preventive and interventional strategies aimed at supporting the holistic health of the youngest patients. Aim This review aims to provide an analysis of available scientific evidence regarding the impact of insufficient sleep duration and poor sleep quality on a wide range of health indicators in children and adolescents. Special emphasis is placed on the consequences for mental health and eating disorders. Materials and methods This review synthesizes current evidence by examining literature available on PubMed, Google Scholar, and academic sources using keywords related to the sleep duration, sleep quality, pediatric population, mental health and eating disorders. Experimental, cohort, systematic reviews and clinical studies were evaluated. Results We highlight sex- and age-dependent vulnerabilities and discuss the multifactorial interplay between sleep behavior, lifestyle factors, and disease risk.Specifically, interventions aimed at improving sleep hygiene, reducing screen exposure before bedtime, and addressing sleep disorders such as obstructive sleep apnea show promise in mitigating risks associated with obesity, hypertension, emotional disorders, and chronic inflammation. Conclusion Sleep duration and sleep quality contributes to pediatric obesity, insulin resistance, cardiometabolic risk, mental health, inflammatory processes and headache disorders. Limitations in current research, including methodological heterogeneity and reliance on subjective sleep measures, underscore the need for prospective studies. We recommend future research focus on mechanistic pathways linking sleep disturbances to specific health outcomes.
- 7 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Open AccessThe impact of sleep duration and quality on the health of the pediatric population: consequences for mental health, eating disorders, and other diseases
Background Sleep is a fundamental biological process, the duration and quality of which are of key importance for the proper development and health of the pediatric population. Understanding the complex relationship between sleep and the pathogenesis of diseases during childhood is essential for developing effective preventive and interventional strategies aimed at supporting the holistic health of the youngest patients. Aim This review aims to provide an analysis of available scientific evidence regarding the impact of insufficient sleep duration and poor sleep quality on a wide range of health indicators in children and adolescents. Special emphasis is placed on the consequences for mental health and eating disorders. Materials and methods This review synthesizes current evidence by examining literature available on PubMed, Google Scholar, and academic sources using keywords related to the sleep duration, sleep quality, pediatric population, mental health and eating disorders. Experimental, cohort, systematic reviews and clinical studies were evaluated. Results We highlight sex- and age-dependent vulnerabilities and discuss the multifactorial interplay between sleep behavior, lifestyle factors, and disease risk.Specifically, interventions aimed at improving sleep hygiene, reducing screen exposure before bedtime, and addressing sleep disorders such as obstructive sleep apnea show promise in mitigating risks associated with obesity, hypertension, emotional disorders, and chronic inflammation. Conclusion Sleep duration and sleep quality contributes to pediatric obesity, insulin resistance, cardiometabolic risk, mental health, inflammatory processes and headache disorders. Limitations in current research, including methodological heterogeneity and reliance on subjective sleep measures, underscore the need for prospective studies. We recommend future research focus on mechanistic pathways linking sleep disturbances to specific health outcomes.
- Open Access
- 5 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
The Mechanistic Target of Rapamycin (mTOR) Pathway as a Target of Anti-aging Therapies: The Role of Rapamycin and Its Analogs in the Regulation of Cellular Processes and Their Impact on Longevity
Aging of the body is a complex, multifactorial biological process, leading to a gradual loss of homeostasis, accumulation of molecular damage, and an increase in susceptibility to civilization diseases. In the face of a global aging population, pharmacological strategies are intensively sought that could slow down or partially reverse the aging process. One of the best-understood molecular pathways for regulating lifespan is the mechanistic target of rapamycin (mTOR) pathway, which integrates metabolic, hormonal, and environmental signals. Inhibition of mTOR, through the use of rapamycin and its analogs, consistently prolongs life in numerous animal models, improving age-related physiological functions. Preclinical evidence indicates that rapamycin prolongs the life of animals, improves metabolism, heart function, cognitive abilities, and immunity. In human clinical trials, low doses of rapamycin improve the immune response, reduce markers of skin aging, and are well tolerated. Rapamycin opens a new chapter in research into pharmacological slowing of aging. Understanding its effects on mTOR and autophagy could enable the development of effective interventions to support human longevity and metabolic health in the future, making these substances a promising direction for further research.
- 5 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Open AccessThe Mechanistic Target of Rapamycin (mTOR) Pathway as a Target of Anti-aging Therapies: The Role of Rapamycin and Its Analogs in the Regulation of Cellular Processes and Their Impact on Longevity
Aging of the body is a complex, multifactorial biological process, leading to a gradual loss of homeostasis, accumulation of molecular damage, and an increase in susceptibility to civilization diseases. In the face of a global aging population, pharmacological strategies are intensively sought that could slow down or partially reverse the aging process. One of the best-understood molecular pathways for regulating lifespan is the mechanistic target of rapamycin (mTOR) pathway, which integrates metabolic, hormonal, and environmental signals. Inhibition of mTOR, through the use of rapamycin and its analogs, consistently prolongs life in numerous animal models, improving age-related physiological functions. Preclinical evidence indicates that rapamycin prolongs the life of animals, improves metabolism, heart function, cognitive abilities, and immunity. In human clinical trials, low doses of rapamycin improve the immune response, reduce markers of skin aging, and are well tolerated. Rapamycin opens a new chapter in research into pharmacological slowing of aging. Understanding its effects on mTOR and autophagy could enable the development of effective interventions to support human longevity and metabolic health in the future, making these substances a promising direction for further research.
- Open Access
- 29 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 47, 66794
The influence of the microbiome on the development and course of bronchial asthma – a comprehensive review
Background Asthma is a chronic airway disease increasingly linked to alterations in the human microbiome. Early-life disruptions in gut, airway, and skin microbiota are associated with impaired immune maturation and higher susceptibility to asthma and allergies. Aim The aim of this study is to review current knowledge on how the human microbiome influences the development, course, and severity of bronchial asthma, including its role in immune regulation, asthma phenotypes, the gut-lung axis, and potential microbiome-based therapies. Materials and Methods This review integrates current evidence using literature from PubMed, Google Scholar, and academic texts with keywords related to the microbiome, gut–lung axis, asthma, dysbiosis, and microbiome-targeted interventions. Experimental, cohort, and clinical studies were analysed. Results The microbiome plays a crucial role in asthma development, especially early in life. Microbial composition is shaped by delivery mode, breastfeeding, antibiotic exposure, and environmental diversity. Cesarean delivery and persistent dysbiosis increase asthma risk, while breastfeeding promotes protective profiles. Early gut dysbiosis - such as reduced SCFA-producing bacteria - affects immune maturation and contributes to distinct asthma phenotypes. Airway colonization by Proteobacteria (e.g., Haemophilus, Moraxella) is associated with severe disease, steroid resistance, and frequent exacerbations. Microbiome-targeted strategies, including probiotics, postbiotics, and fecal microbiota transplantation, show therapeutic potential. Conclusions The microbiome is a key regulator of immune development and a major contributor to asthma risk. Microbiome-based interventions are promising but require further well-designed clinical research.
- 29 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 47, 66794
Open AccessThe influence of the microbiome on the development and course of bronchial asthma – a comprehensive review
Background Asthma is a chronic airway disease increasingly linked to alterations in the human microbiome. Early-life disruptions in gut, airway, and skin microbiota are associated with impaired immune maturation and higher susceptibility to asthma and allergies. Aim The aim of this study is to review current knowledge on how the human microbiome influences the development, course, and severity of bronchial asthma, including its role in immune regulation, asthma phenotypes, the gut-lung axis, and potential microbiome-based therapies. Materials and Methods This review integrates current evidence using literature from PubMed, Google Scholar, and academic texts with keywords related to the microbiome, gut–lung axis, asthma, dysbiosis, and microbiome-targeted interventions. Experimental, cohort, and clinical studies were analysed. Results The microbiome plays a crucial role in asthma development, especially early in life. Microbial composition is shaped by delivery mode, breastfeeding, antibiotic exposure, and environmental diversity. Cesarean delivery and persistent dysbiosis increase asthma risk, while breastfeeding promotes protective profiles. Early gut dysbiosis - such as reduced SCFA-producing bacteria - affects immune maturation and contributes to distinct asthma phenotypes. Airway colonization by Proteobacteria (e.g., Haemophilus, Moraxella) is associated with severe disease, steroid resistance, and frequent exacerbations. Microbiome-targeted strategies, including probiotics, postbiotics, and fecal microbiota transplantation, show therapeutic potential. Conclusions The microbiome is a key regulator of immune development and a major contributor to asthma risk. Microbiome-based interventions are promising but require further well-designed clinical research.
- Open Access
- 20 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 46
Smarter, Faster, Safer: How AI Is Rewiring Sports, Performance Science, and Athlete Health
Background. Artificial intelligence (AI) is rapidly permeating sports medicine and performance science, propelled by high-volume data from wearables, video, and clinical systems. Beyond traditional analytics, modern machine learning (ML) and deep learning (DL) can model complex, nonlinear relationships to support diagnosis, injury prevention, load management, and tactical decisions. Yet adoption remains uneven due to concerns about data quality, bias, interpretability, governance, and the appropriate balance between automation and expert judgment. Aim. To synthesize emerging evidence on AI applications across sports medicine and performance optimization, clarifying opportunities, constraints, and ethical considerations required for safe, effective, and equitable integration. Material and methods. Narrative review of AI modalities, core data ecosystems and representative use cases spanning MSK imaging, injury-risk modeling, movement analysis, recovery optimization, and tactical decision support. The review emphasizes multimodal data fusion, model oversight, and real-world implementation factors. Current state of knowledge. Evidence indicates AI can enhance diagnostic speed and accuracy in MSK imaging, improve early detection of overuse and acute injury risk via spatiotemporal and physiological signals. enable individualized load management and adaptive training through time-series modeling; and support coaching and education via NLP and LLM-powered tools. Key limitations include dataset heterogeneity, biased sampling and gaps between prototype performance and field deployment. Conclusions. AI can make training and care more precise, proactive, and accessible, but benefits hinge on high-quality data pipelines, transparent models, clinician/coach oversight, and ethical safeguards. Interdisciplinary collaboration is essential to realize performance gains while protecting athlete welfare and equity.
- 20 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 46
Open AccessSmarter, Faster, Safer: How AI Is Rewiring Sports, Performance Science, and Athlete Health
Background. Artificial intelligence (AI) is rapidly permeating sports medicine and performance science, propelled by high-volume data from wearables, video, and clinical systems. Beyond traditional analytics, modern machine learning (ML) and deep learning (DL) can model complex, nonlinear relationships to support diagnosis, injury prevention, load management, and tactical decisions. Yet adoption remains uneven due to concerns about data quality, bias, interpretability, governance, and the appropriate balance between automation and expert judgment. Aim. To synthesize emerging evidence on AI applications across sports medicine and performance optimization, clarifying opportunities, constraints, and ethical considerations required for safe, effective, and equitable integration. Material and methods. Narrative review of AI modalities, core data ecosystems and representative use cases spanning MSK imaging, injury-risk modeling, movement analysis, recovery optimization, and tactical decision support. The review emphasizes multimodal data fusion, model oversight, and real-world implementation factors. Current state of knowledge. Evidence indicates AI can enhance diagnostic speed and accuracy in MSK imaging, improve early detection of overuse and acute injury risk via spatiotemporal and physiological signals. enable individualized load management and adaptive training through time-series modeling; and support coaching and education via NLP and LLM-powered tools. Key limitations include dataset heterogeneity, biased sampling and gaps between prototype performance and field deployment. Conclusions. AI can make training and care more precise, proactive, and accessible, but benefits hinge on high-quality data pipelines, transparent models, clinician/coach oversight, and ethical safeguards. Interdisciplinary collaboration is essential to realize performance gains while protecting athlete welfare and equity.